JP2016516725A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516725A5 JP2016516725A5 JP2016503195A JP2016503195A JP2016516725A5 JP 2016516725 A5 JP2016516725 A5 JP 2016516725A5 JP 2016503195 A JP2016503195 A JP 2016503195A JP 2016503195 A JP2016503195 A JP 2016503195A JP 2016516725 A5 JP2016516725 A5 JP 2016516725A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- polynucleotide
- pro
- bax
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361800354P | 2013-03-15 | 2013-03-15 | |
| US61/800,354 | 2013-03-15 | ||
| PCT/US2014/029685 WO2014145042A1 (en) | 2013-03-15 | 2014-03-14 | Treatment of autoimmune diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019010717A Division JP2019077715A (ja) | 2013-03-15 | 2019-01-25 | 自己免疫疾患の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516725A JP2016516725A (ja) | 2016-06-09 |
| JP2016516725A5 true JP2016516725A5 (enExample) | 2017-04-20 |
| JP6499155B2 JP6499155B2 (ja) | 2019-04-10 |
Family
ID=51537869
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503195A Active JP6499155B2 (ja) | 2013-03-15 | 2014-03-14 | 自己免疫疾患の治療 |
| JP2019010717A Pending JP2019077715A (ja) | 2013-03-15 | 2019-01-25 | 自己免疫疾患の治療 |
| JP2021047124A Pending JP2021091742A (ja) | 2013-03-15 | 2021-03-22 | 自己免疫疾患の治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019010717A Pending JP2019077715A (ja) | 2013-03-15 | 2019-01-25 | 自己免疫疾患の治療 |
| JP2021047124A Pending JP2021091742A (ja) | 2013-03-15 | 2021-03-22 | 自己免疫疾患の治療 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2968606B1 (enExample) |
| JP (3) | JP6499155B2 (enExample) |
| CN (2) | CN105451777A (enExample) |
| AU (2) | AU2014233428B2 (enExample) |
| CA (1) | CA2902565C (enExample) |
| DK (1) | DK2968606T3 (enExample) |
| ES (1) | ES2825078T3 (enExample) |
| WO (1) | WO2014145042A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2758074T3 (da) | 2011-09-23 | 2020-07-27 | Univ Loma Linda | Bakteriestammer der udtrykker methylasegener og anvendelser deraf |
| US11680273B2 (en) | 2011-09-23 | 2023-06-20 | Loma Linda University | Treatment of autoimmune diseases |
| CN105451777A (zh) * | 2013-03-15 | 2016-03-30 | 洛马林达大学 | 自身免疫性疾病的治疗 |
| WO2016135732A1 (en) * | 2015-02-26 | 2016-09-01 | Yeda Research And Development Co. Ltd. | Method of promoting hair growth |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| DE3223885A1 (de) | 1982-06-26 | 1983-12-29 | Basf Ag, 6700 Ludwigshafen | Makroporoese, hydrophile traeger fuer enzyme |
| US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5100792A (en) | 1984-11-13 | 1992-03-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4663161A (en) | 1985-04-22 | 1987-05-05 | Mannino Raphael J | Liposome methods and compositions |
| US4871488A (en) | 1985-04-22 | 1989-10-03 | Albany Medical College Of Union University | Reconstituting viral glycoproteins into large phospholipid vesicles |
| US5179022A (en) | 1988-02-29 | 1993-01-12 | E. I. Du Pont De Nemours & Co. | Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner |
| US5693622A (en) | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
| US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US6132419A (en) | 1992-05-22 | 2000-10-17 | Genetronics, Inc. | Electroporetic gene and drug therapy |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| US5993434A (en) | 1993-04-01 | 1999-11-30 | Genetronics, Inc. | Method of treatment using electroporation mediated delivery of drugs and genes |
| AU686277B2 (en) | 1993-11-16 | 1998-02-05 | Pacira Pharmaceuticals, Inc. | Vesicles with controlled release of actives |
| US5549127A (en) | 1995-05-03 | 1996-08-27 | Chang; Wen-Hsiung | Spring fixing structure for a hairgrip |
| US5763270A (en) | 1995-06-07 | 1998-06-09 | Genemedicine, Inc. | Plasmid for delivery of nucleic acids to cells and methods of use |
| EP0914094A4 (en) | 1996-03-28 | 2000-03-01 | Univ Illinois | MATERIALS AND METHOD FOR PRODUCING IMPROVED LIPOSOMAL AGENTS |
| US5851818A (en) | 1996-05-31 | 1998-12-22 | Sequus Pharmaceuticals, Inc. | Condensed plasmid-liposome complex for transfection |
| US5827533A (en) | 1997-02-06 | 1998-10-27 | Duke University | Liposomes containing active agents aggregated with lipid surfactants |
| US6233483B1 (en) | 1997-05-14 | 2001-05-15 | Pacesetter, Inc. | System and method for generating a high efficiency biphasic defibrillation waveform for use in an implantable cardioverter/defibrillator (ICD). |
| US6200598B1 (en) | 1998-06-18 | 2001-03-13 | Duke University | Temperature-sensitive liposomal formulation |
| US6800484B2 (en) | 1998-06-24 | 2004-10-05 | Genetronics, Inc. | High efficiency transfection based on low electric field strength, long pulse length |
| AU2868200A (en) | 1999-02-08 | 2000-08-25 | Chiron Corporation | Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo |
| EP1890606A1 (en) * | 2005-04-25 | 2008-02-27 | Koninklijke Philips Electronics N.V. | Method and apparatus for continuous imaging by ultrasound transducer system |
| US20090191218A1 (en) * | 2005-05-11 | 2009-07-30 | Fengchun Li | DNA Vaccines And Methods For The Prevention Of Transplantation Rejection |
| US8778327B2 (en) * | 2005-05-11 | 2014-07-15 | Loma Linda University | Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders |
| WO2009114735A1 (en) * | 2008-03-12 | 2009-09-17 | Loma Linda University | Dna vaccines and methods for the prevention of transplantation rejection |
| EP2542698B1 (en) | 2010-03-03 | 2015-04-22 | Zymo Research Corporation | Detection of dna methylation |
| DK2758074T3 (da) * | 2011-09-23 | 2020-07-27 | Univ Loma Linda | Bakteriestammer der udtrykker methylasegener og anvendelser deraf |
| CN105451777A (zh) * | 2013-03-15 | 2016-03-30 | 洛马林达大学 | 自身免疫性疾病的治疗 |
-
2014
- 2014-03-14 CN CN201480015896.9A patent/CN105451777A/zh active Pending
- 2014-03-14 WO PCT/US2014/029685 patent/WO2014145042A1/en not_active Ceased
- 2014-03-14 EP EP14764420.7A patent/EP2968606B1/en active Active
- 2014-03-14 CN CN201910567251.0A patent/CN110237270A/zh active Pending
- 2014-03-14 AU AU2014233428A patent/AU2014233428B2/en active Active
- 2014-03-14 JP JP2016503195A patent/JP6499155B2/ja active Active
- 2014-03-14 CA CA2902565A patent/CA2902565C/en active Active
- 2014-03-14 DK DK14764420.7T patent/DK2968606T3/da active
- 2014-03-14 ES ES14764420T patent/ES2825078T3/es active Active
-
2019
- 2019-01-25 JP JP2019010717A patent/JP2019077715A/ja active Pending
- 2019-08-23 AU AU2019219835A patent/AU2019219835B2/en active Active
-
2021
- 2021-03-22 JP JP2021047124A patent/JP2021091742A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Merten et al. | Viral vectors for gene therapy and gene modification approaches | |
| WO2017077329A3 (en) | Nucleic acids, peptides and methods | |
| PH12021551155A1 (en) | Recombinant viral vectors and nucleic acids for producing the same | |
| WO2018033254A3 (en) | Rna for cancer therapy | |
| MX2021000810A (es) | Sistemas y metodos para producir formulaciones de terapia genetica. | |
| PH12019500694A1 (en) | Factor viii compositions and methods of making and using the same | |
| MX359953B (es) | Ácido nucleico que comprende o que codifica un tallo-rizo de histona y una secuencia poli (a) o una señal de poliadenilación para incrementar la expresión de una proteína terapéutica codificada. | |
| MX2022010175A (es) | Proteinas de union a flt3 y metodos de uso. | |
| WO2017191274A3 (en) | Rna encoding a therapeutic protein | |
| MX2022005291A (es) | Vacunas para el tratamiento y prevencion del cancer. | |
| JP2014000092A5 (enExample) | ||
| EA201591281A1 (ru) | Рибонуклеиновые кислоты с 4'-тиомодифицированными нуклеотидами и связанные с ними способы | |
| JP2016516725A5 (enExample) | ||
| MX2022010959A (es) | Terapia genica para trastornos oculares. | |
| JP2018520646A5 (enExample) | ||
| TW201613954A (en) | Interleukin-10 fusion proteins and uses thereof | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| EP3747457A3 (en) | Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases | |
| NZ629427A (en) | Methods and compositions for treating huntington’s disease | |
| MX2021009696A (es) | Vectores de genoterapia para el tratamiento de la enfermedad de danon. | |
| NZ628385A (en) | Batches of recombinant adenovirus with altered terminal ends | |
| WO2020214809A3 (en) | Gene therapies for stargardt disease (abca4) | |
| MX2021006253A (es) | Terapias génicas para enfermedad neurodegenerativa. | |
| JP2018537089A5 (enExample) | ||
| PH12019502442A1 (en) | Variants of human bmp7 protein |